J7657 HCPCS Level II code: Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
J7657 is the HCPCS code for “Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Short description: Isoproterenol comp con
HCPCS · United States
Medicare details
The indicators CMS publishes with J7657 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Carrier judgment
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Drugs Administered through DME
- Added
- Jan 1, 2007
Where J7657 sits
- 1J codesDrugs administered other than orally
- 2Active code J7657Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J7657 mean?
J7657 is the HCPCS code for “Isoproterenol hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligram” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J7657?
CMS lists J7657’s Medicare coverage as “Carrier judgment” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J7657
All J codesJ7644Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7645Ipratropium bromide, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7647Isoetharine hcl, inhalation solution, compounded product, administered through dme, concentrated form, per milligramJ7648Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligramJ7649Isoetharine hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7650Isoetharine hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7658Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per milligramJ7659Isoproterenol hcl, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligramJ7660Isoproterenol hcl, inhalation solution, compounded product, administered through dme, unit dose form, per milligramJ7665Mannitol, administered through an inhaler, 5 mgJ7667Metaproterenol sulfate, inhalation solution, compounded product, concentrated form, per 10 milligramsJ7668Metaproterenol sulfate, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 10 milligrams